Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A3 | P48764 | 11/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopropane SCHEMBL4035772 | 1.00 | SLC9A3 (0.54) | SLC9A3 | |
| Cyclopentane SCHEMBL4029948 | 1.00 | SLC9A3 (0.54) | SLC9A3 | |
| SCHEMBL4031638 | 0.98 | SLC9A3 (0.56) | SLC9A3 | |
| SCHEMBL2576031 | 0.89 | SLC9A3 (0.54) | SLC9A3 | |
| Cyclopropane SCHEMBL4034970 | 0.89 | SLC9A3 (0.66) | SLC9A3 | |
| SCHEMBL4026043 | 0.89 | SLC9A3 (0.66) | SLC9A3 | |
| Cyclopentane SCHEMBL4026133 | 0.89 | SLC9A3 (0.66) | SLC9A3 | |
| SCHEMBL23469864 | 0.88 | SLC9A3 (0.55) | SLC9A3 | |
| Hydrochloric Acid SCHEMBL4030085 | 0.88 | SLC9A3 (0.53) | SLC9A3 | |
| SCHEMBL5756042 | 0.88 | SLC9A3 (0.53) | SLC9A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1453810-B1 | SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD FOR THE PRODUCTION THEREOF, THE USE THEREOF AS MEDICAMENTS, IN ADDITION TO A MEDICAMENT CONTAINING SAME | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-03-18 | — | — | EP | claimed |
| EP-1453810-B1 | SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD FOR THE PRODUCTION THEREOF, THE USE THEREOF AS MEDICAMENTS, IN ADDITION TO A MEDICAMENT CONTAINING SAME | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-03-18 | — | — | EP | disclosed |